These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 38959606)
1. The investigation of potential mechanism of Fuzhengkangfu Decoction against Diabetic myocardial injury based on a combined strategy of network pharmacology, transcriptomics, and experimental verification. Li M; Chen L; Liu X; Wu Y; Chen X; Chen H; Zhong Y; Xu Y Biomed Pharmacother; 2024 Aug; 177():117048. PubMed ID: 38959606 [TBL] [Abstract][Full Text] [Related]
2. [Mechanism of Shexiang Tongxin Dropping Pills in treating diabetic cardiomyopathy based on network pharmacology and animal experiments]. Bai YL; Cui XY; Yuan YY; Zhang YT; Wang W; Liu TH; Wu Y Zhongguo Zhong Yao Za Zhi; 2024 Apr; 49(7):1905-1914. PubMed ID: 38812203 [TBL] [Abstract][Full Text] [Related]
3. Matrine pretreatment improves cardiac function in rats with diabetic cardiomyopathy via suppressing ROS/TLR-4 signaling pathway. Liu ZW; Wang JK; Qiu C; Guan GC; Liu XH; Li SJ; Deng ZR Acta Pharmacol Sin; 2015 Mar; 36(3):323-33. PubMed ID: 25619390 [TBL] [Abstract][Full Text] [Related]
4. [Compound Zhang W; Gu H; Chen P; Wu S; Ma H; Yao L Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jul; 44(7):1306-1314. PubMed ID: 39051076 [TBL] [Abstract][Full Text] [Related]
5. Nimbolide protects against diabetic cardiomyopathy by regulating endoplasmic reticulum stress and mitochondrial function via the Akt/mTOR pathway. Zhang H; Zhao X; Wei W; Shen C Tissue Cell; 2024 Oct; 90():102478. PubMed ID: 39053131 [TBL] [Abstract][Full Text] [Related]
6. Network Pharmacology-Based Strategy Reveals the Effects of Zhang S; Yuan Z; Wu H; Li W; Li L; Huang H Biomed Res Int; 2020; 2020():8260703. PubMed ID: 33134388 [TBL] [Abstract][Full Text] [Related]
7. Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress. Gu X; Shi Y; Chen X; Sun Z; Luo W; Hu X; Jin G; You S; Qian Y; Wu W; Liang G; Wu G; Chen Z; Chen X Phytomedicine; 2020 Nov; 78():153319. PubMed ID: 32950951 [TBL] [Abstract][Full Text] [Related]
8. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway. Liu X; Guo B; Zhang W; Ma B; Li Y J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411 [TBL] [Abstract][Full Text] [Related]
9. H3 Relaxin Protects Against Myocardial Injury in Experimental Diabetic Cardiomyopathy by Inhibiting Myocardial Apoptosis, Fibrosis and Inflammation. Zhang X; Pan L; Yang K; Fu Y; Liu Y; Chi J; Zhang X; Hong S; Ma X; Yin X Cell Physiol Biochem; 2017; 43(4):1311-1324. PubMed ID: 28992627 [TBL] [Abstract][Full Text] [Related]
10. Astragalus polysaccharides inhibits cardiomyocyte apoptosis during diabetic cardiomyopathy via the endoplasmic reticulum stress pathway. Sun S; Yang S; An N; Wang G; Xu Q; Liu J; Mao Y J Ethnopharmacol; 2019 Jun; 238():111857. PubMed ID: 30959142 [TBL] [Abstract][Full Text] [Related]
11. Effects of resveratrol on regulation on UCP2 and cardiac function in diabetic rats. Diao J; Wei J; Yan R; Fan G; Lin L; Chen M J Physiol Biochem; 2019 Feb; 75(1):39-51. PubMed ID: 30225723 [TBL] [Abstract][Full Text] [Related]
12. Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats. Yu W; Wu J; Cai F; Xiang J; Zha W; Fan D; Guo S; Ming Z; Liu C PLoS One; 2012; 7(12):e52013. PubMed ID: 23251674 [TBL] [Abstract][Full Text] [Related]
13. Exploring the mechanism of diabetic cardiomyopathy treated with Qigui Qiangxin mixture based on UPLC-Q/TOF-MS, network pharmacology and experimental validation. Han Q; Li Y; Yu Y; Yuan H; Wang Z; Guo Y; Shi J; Xue Y; Liu X Sci Rep; 2024 May; 14(1):12119. PubMed ID: 38802644 [TBL] [Abstract][Full Text] [Related]
14. Farrerol Alleviates Diabetic Cardiomyopathy by Regulating AMPK-Mediated Cardiac Lipid Metabolic Pathways in Type 2 Diabetic Rats. Tu J; Liu Q; Sun H; Gan L Cell Biochem Biophys; 2024 Sep; 82(3):2427-2437. PubMed ID: 38878100 [TBL] [Abstract][Full Text] [Related]
15. Apoptosis of cardiomyocytes in diabetic cardiomyopathy involves overexpression of glycogen synthase kinase-3β. Wu W; Liu X; Han L Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30237226 [TBL] [Abstract][Full Text] [Related]
16. Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid. Li CJ; Lv L; Li H; Yu DM Cardiovasc Diabetol; 2012 Jun; 11():73. PubMed ID: 22713251 [TBL] [Abstract][Full Text] [Related]
17. An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress. You S; Qian J; Sun C; Zhang H; Ye S; Chen T; Xu Z; Wang J; Huang W; Liang G J Cell Mol Med; 2018 Mar; 22(3):1931-1943. PubMed ID: 29327811 [TBL] [Abstract][Full Text] [Related]
18. Low molecular weight fucoidan alleviates cardiac dysfunction in diabetic Goto-Kakizaki rats by reducing oxidative stress and cardiomyocyte apoptosis. Yu X; Zhang Q; Cui W; Zeng Z; Yang W; Zhang C; Zhao H; Gao W; Wang X; Luo D J Diabetes Res; 2014; 2014():420929. PubMed ID: 25525607 [TBL] [Abstract][Full Text] [Related]
19. Kaempferol attenuates hyperglycemia-induced cardiac injuries by inhibiting inflammatory responses and oxidative stress. Chen X; Qian J; Wang L; Li J; Zhao Y; Han J; Khan Z; Chen X; Wang J; Liang G Endocrine; 2018 Apr; 60(1):83-94. PubMed ID: 29392616 [TBL] [Abstract][Full Text] [Related]
20. Bicyclol Alleviates Streptozotocin-induced Diabetic Cardiomyopathy By Inhibiting Chronic Inflammation And Oxidative Stress. Zhang L; Hu C; Jin B; Bai B; Liao J; Jin L; Wang M; Zhu W; Wu X; Zheng L; Xu X; Jiang Y; Wang Y; He Y Cardiovasc Drugs Ther; 2024 Jun; 38(3):555-568. PubMed ID: 36662448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]